Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The funding will enable Elevian to submit an investigational new drug application, scale manufacturing and complete Phase 1 clinical trials for GDF11, for lead indication of stroke recovery.
Lead Product(s): rGDF11
Therapeutic Area: Neurology Product Name: rGDF11
Highest Development Status: PreclinicalProduct Type: Large molecule
Partner/Sponsor/Collaborator: Prime Movers Lab
Deal Size: $40.0 million Upfront Cash: Undisclosed
Deal Type: Series A Financing September 16, 2021
Details:
Proceeds from the equity financing will enable Elevian to advance recombinant GDF11 (rGDF11) toward the clinic to treat stroke and other age-related diseases.
Lead Product(s): rGDF11
Therapeutic Area: Neurology Product Name: rGDF11
Highest Development Status: PreclinicalProduct Type: Large molecule
Partner/Sponsor/Collaborator: Prime Movers Lab
Deal Size: $15.0 million Upfront Cash: Undisclosed
Deal Type: Financing November 24, 2020